Defunct Company
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
465
NCT00587691
Dose-Escalation Study of T Cell Vaccine in Multiple Sclerosis
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jul 31, 2002
Completion: Dec 31, 2008
NCT00245622
Autologous T Cell Vaccine (TCV) for Multiple Sclerosis
Phase: Phase 2
Start: May 31, 2006
Completion: Sep 30, 2008
NCT00595920
Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis
Start: Nov 30, 2007
NCT01684761
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
Start: Aug 31, 2012
Completion: Oct 31, 2016